PREDICT TRIAL- Neoadjuvant Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women Expressing Hormonal Receptors ( ER and PR).
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Letrozole (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms PREDICT
- Sponsors Novartis
- 09 Dec 2010 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 09 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jul 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.